Stem Cell Transplantation
HSCT feasible in infants with acute lymphoblastic leukemia
Published in Blood Weekly, March 2nd, 2006
"Infants with acute lymphoblastic leukemia (ALL) have a poor prognosis when treated with standard chemotherapy. A subset of these infants, particularly those with mixed-lineage leukemia (MLL) rearrangements, has a high likelihood of relapse.
"Hematopoietic stem cell transplantation (HSCT) performed early in first remission may improve outcome," scientists in the United States report.
According to D.A. Jacobsohn and colleagues at Children's Memorial Hospital in Chicago, "We present the results of 16 patients with infant ALL who were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-03-02)
More Articles from Blood Weekly
- Cardiovascular Research
Engineered heart tissue offers insights into irregular heartbeats - Stem Cell Transplantation
High cure rate of isolated CNS relapse by ASCT in pediatric acute lymphoblastic leukemia - Tissue Engineering
Bioactive scaffold supports fibroblast growth for connective tissue regeneration - Tissue Engineering
Hepatocyte culture system developed - Acute Myeloid Leukemia
Impaired C/EBP alpha function contributes directly to AML development - Alopecia
Alopecia a frequent complication in women receiving tacrolimus after SPK transplantation - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
